Polynovo Ltd PNV
Trading Information
- Previous Close Price
- A$2.64
- Day Range
- A$2.57–2.64
- 52-Week Range
- A$1.10–2.78
- Bid/Ask
- A$2.57 / A$2.62
- Market Cap
- A$1.80 Bil
- Volume/Avg
- 949,389 / 1.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 214.18
- Price/Sales
- 17.74
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita’s RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 8
- Website
- https://www.polynovo.com
Competitors
Valuation
|
Metric
|
PNV
|
NAN
|
FPH
|
|---|---|---|---|
Price/Earnings (Normalized) | 214.18 | 70.22 | 96.96 |
Price/Book Value | 24.98 | 6.14 | 11.54 |
Price/Sales | 17.74 | 6.64 | 11.60 |
Price/Cash Flow | 497.14 | 50.83 | 47.46 |
Price/Earnings
PNV
NAN
FPH
Financial Strength
|
Metric
|
PNV
|
NAN
|
FPH
|
|---|---|---|---|
Quick Ratio | 2.87 | 5.25 | 0.88 |
Current Ratio | 3.41 | 6.16 | 1.83 |
Interest Coverage | 1.24 | 8.25 | 13.77 |
Quick Ratio
PNV
NAN
FPH
Profitability
|
Metric
|
PNV
|
NAN
|
FPH
|
|---|---|---|---|
Return on Assets (Normalized) | 6.37% | 6.94% | 11.54% |
Return on Equity (Normalized) | 9.21% | 9.11% | 15.07% |
Return on Invested Capital (Normalized) | 6.83% | 7.18% | 13.94% |
Return on Assets
PNV
NAN
FPH
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Czbbhwhm | Dggtbr | $195.6 Bil | |||
| Stryker Corp
SYK
| Nygyrtymk | Rgw | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Jqygywvt | Mjrbm | $122.7 Bil | |||
| Medtronic PLC
MDT
| Qxwtxnbjh | Fnhrrp | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Wfvntnztgd | Nhzwsb | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Ntlkt | Rcjx | $30.7 Bil | |||
| DexCom Inc
DXCM
| Pdxnyyfv | Qsch | $27.0 Bil | |||
| Steris PLC
STE
| Sklgqszmf | Zmgcsl | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Mbthkbgtpj | Trmc | $22.0 Bil | |||
| Insulet Corp
PODD
| Hzjdstgk | Cvgvdcz | $16.3 Bil |
United States